SCHEMBL4895135

SCHEMBL4895135

O=C(Nc1cccc(Cl)c1)N(S)c1cccc(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.58
KMT2A Q03164 8/20 0.58
HSP90AA1 P07900 1/20 0.58
LMNA P02545 4/20 0.57
MAPT P10636 4/20 0.57
ALDH1A1 P00352 3/20 0.57
HTT P42858 2/20 0.57
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.51
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NOX1 Q9Y5S8 1/20 0.51
USP2 O75604 1/20 0.51
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811424 0.83 MEN1 (0.49) MEN1KMT2AHSP90AA1LMNAMAPT
SCHEMBL6815125 0.83 MEN1 (0.58) MEN1KMT2AHSP90AA1LMNAMAPT
SCHEMBL6810635 0.77 RAB9A (0.53) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL28429878 0.77 MEN1 (0.60) MEN1KMT2AHSP90AA1LMNAMAPT
SCHEMBL2461958 0.77 MEN1 (0.65) MEN1KMT2AHSP90AA1LMNAMAPT
SCHEMBL6816886 0.76 MEN1 (0.53) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL11260248 0.76 HTR3E (0.43) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL30503043 0.75 MAPT (0.74) MEN1KMT2AHSP90AA1LMNAMAPT
SCHEMBL653293 0.75 HTR3E (0.50) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL5353973 0.74 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027044-A1 Prodrug antibiotic screens NORTHEASTERN UNIVERSITY 2008-01-31 US disclosed
US-5443909-A Heat sensitive recordin material; substrate, recording layer containing colorless basic dye and protective coatings KANZAKI PAPER MANUFACTURING CO., LTD. (JP) 1995-08-22 US disclosed
US-5439869-A Substrate coated with a mixture of a bisphenol carboxylic acid, one basic compound, and a color developer; colorfastness, storage stability, chemical resistance BAYER AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
US-5292712-A Salt of a bisphenol carboxylic acid BAYER AKTIENGESELLSCHAFT (DE) 1994-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027044-A1 Prodrug antibiotic screens O60361, PGLS, GUSB MEN1 3696/4885KMT2A 3307/4885HSP90AA1 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.